SecSonar.com

Vyome Holdings, Inc. (HIND)

Vyome Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Vyome Holdings, Inc. (HIND) is a Biotechnology company based in US with a market capitalization of $13M. Revenue declined 96.0% year-over-year and free cash flow was negative at -$3.7M. This page tracks HIND's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 18 employees · IPO Oct 6, 2016

Valuation

Valuation & price

$1.89 · as of May 17, 2026 · -87.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.33

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$14.00$7.95$1.89Jul 25Dec 25Jul 26Jul 7, 25$9.52Jul 9, 25$10.00Jul 11, 25$9.52Jul 15, 25$10.72Jul 17, 25$11.40Jul 21, 25$11.64Jul 23, 25$13.40Jul 25, 25$9.92Jul 29, 25$9.32Jul 31, 25$9.76Aug 4, 25$9.96Aug 6, 25$10.32Aug 11, 25$7.52Aug 13, 25$12.80Aug 15, 25$14.00Aug 19, 25$9.02Aug 21, 25$10.96Aug 25, 25$11.28Aug 27, 25$10.63Aug 29, 25$9.20Sep 3, 25$8.56Sep 5, 25$7.95Sep 9, 25$7.92Sep 11, 25$7.54Sep 16, 25$6.05Sep 18, 25$6.61Sep 22, 25$5.79Sep 24, 25$5.46Sep 26, 25$5.17Sep 30, 25$5.18Oct 2, 25$5.36Oct 6, 25$5.25Oct 8, 25$5.87Oct 10, 25$5.07Oct 14, 25$5.30Oct 16, 25$5.06Oct 21, 25$5.44Oct 23, 25$5.53Oct 27, 25$5.52Oct 29, 25$5.38Oct 31, 25$6.05Nov 4, 25$6.17Nov 6, 25$5.66Nov 10, 25$5.44Nov 12, 25$5.32Nov 14, 25$4.87Nov 18, 25$4.97Nov 20, 25$4.77Nov 25, 25$5.21Nov 28, 25$5.18Dec 2, 25$4.95Dec 4, 25$5.09Dec 8, 25$5.73Dec 10, 25$4.85Dec 12, 25$4.62Dec 16, 25$4.07Dec 18, 25$3.88Dec 22, 25$3.88Dec 24, 25$3.76Dec 29, 25$3.59Jan 2, 26$3.55Jan 6, 26$3.16Jan 8, 26$3.43Jan 12, 26$3.23Jan 14, 26$3.02Jan 16, 26$2.85Jan 21, 26$2.68Jan 23, 26$3.19Jan 27, 26$3.26Jan 29, 26$2.14Feb 2, 26$2.20Feb 4, 26$2.57Feb 9, 26$2.57Feb 11, 26$2.56Feb 13, 26$2.59Feb 18, 26$2.81Feb 20, 26$2.63Feb 24, 26$3.14Feb 26, 26$3.36Mar 2, 26$3.41Mar 4, 26$3.10Mar 6, 26$2.80Mar 10, 26$2.60Mar 12, 26$2.37Mar 17, 26$2.12Mar 19, 26$2.28Mar 23, 26$2.32Mar 25, 26$2.27Mar 27, 26$2.13Mar 31, 26$2.15Apr 2, 26$2.13Apr 7, 26$2.11Apr 9, 26$2.30Apr 13, 26$2.32Apr 15, 26$2.24Apr 17, 26$2.21Apr 22, 26$2.27Apr 24, 26$2.21Apr 28, 26$2.10Apr 30, 26$2.03May 4, 26$2.09May 6, 26$2.20May 8, 26$2.06May 12, 26$1.98May 14, 26$1.92May 18, 26$1.89May 20, 26$2.11May 22, 26$2.23May 28, 26$2.35Jun 1, 26$2.32Jun 3, 26$2.26Jun 5, 26$2.16Jun 9, 26$2.11Jun 11, 26$2.28Jun 15, 26$2.17Jun 17, 26$2.18Jun 22, 26$2.17Jun 24, 26$2.10Jun 26, 26$2.16Jul 2, 26$2.30
$1.8952-week range$15.68
Loading valuation history…

Fundamentals

Key fundamentals

$13M

Market cap

-96.0%

Revenue growth (YoY)

64.7%

Gross margin

-$3.7M

Free cash flow (USD)

-$5M

Net debt

Net cash position

10380.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$786.7KFY 2017$1.3MFY 2018$606.7KFY 2019$15.1MFY 2020$11.3MFY 2021$13.6MFY 2022$11.2MFY 2023$8.7MFY 2024$8.0MFY 2025$319.7K
$786.7K$319.7K

Free cash flow by year

2016 → 2025

FY 2016$-20.7MFY 2017$-24.7MFY 2018$-27.5MFY 2019$-14.2MFY 2020$-8.9MFY 2021$-15.7MFY 2022$-22.0MFY 2023$-17.0MFY 2024$-4.4MFY 2025$-3.7M
-$20.7M-$3.7M

Gross margin by year

2021 → 2025

FY 202161.4%FY 202260.5%FY 202363.9%FY 202463.2%FY 202564.7%
61.4%64.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings ReleaseMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventAuthorized Shares DecreaseApr 29, 2026Filing

Questions

Frequently asked questions

What is Vyome Holdings, Inc.'s market cap?

Vyome Holdings, Inc. (HIND) has a market capitalization of $13M.

What is HIND's P/E ratio?

A meaningful P/E ratio is not available for HIND — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is HIND's price-to-book (P/B) ratio?

HIND trades at 5.33 times book value per share.

Are insiders buying HIND stock?

SEC Form 4 filings show no open-market insider buys at Vyome Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

LPCN

Lipocine Inc.

$13.2M

GDTC

CytoMed Therapeutics Limited

$13.4M

TRAW

Traws Pharma, Inc.

$13.4M

CYCN

Cyclerion Therapeutics, Inc.

$13.6M

LEXX

Lexaria Bioscience Corp.

$12.2M

TAOX

TAO Synergies Inc.

$14M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.